5 Growth Stocks Under $50 for March 2024 | ORBITAL AFFAIRS

- Advertisement -

**Unlocking the Potential of Growth Stocks in 2024**

- Advertisement -

In the ever-evolving landscape of the stock market, growth stocks have emerged as a beacon of hope for investors seeking above-average returns. Over the past year, growth stocks have surged by an impressive 35%, as evidenced by the SPDR Portfolio S&P 500 Growth ETF (SPYG). Among the standout performers in this category are disruptive insurer Root, Inc., and biotech company EyePoint Pharmaceuticals, Inc., both of which have delivered staggering returns exceeding 700% since March 2023.

- Advertisement -

**Understanding Growth Stocks**

Growth stocks are companies that exhibit the potential for accelerated growth in revenues and earnings. This growth is often attributed to their presence in emerging industries or their possession of unique products or services that confer a competitive advantage. Unlike traditional companies that distribute dividends to shareholders, growth companies typically reinvest their earnings back into the business to fuel further expansion. While these companies offer the promise of high returns, they also come with increased volatility, making them inherently riskier investments.

**Root, Inc. (ROOT)**

- Advertisement -

Root, Inc., operating in the insurance brokers/services sector, has been a standout performer with a remarkable 1-year total return of 847%. The company is revolutionizing the car insurance industry by utilizing driving behavior data to personalize rates for good drivers. With over 13 million app downloads and significant improvements in profitability indicators, Root is poised for continued success in the coming years.

**EyePoint Pharmaceuticals, Inc. (EYPT)**

EyePoint Pharmaceuticals, a player in the health technology/pharmaceuticals sector, has witnessed a phenomenal 1-year total return of 720%. The company’s focus on developing therapeutics for serious retinal diseases, particularly its leading product EYP-901, has garnered widespread acclaim. Positive trial results and a strategic approach to drug delivery technology have propelled EyePoint Pharmaceuticals to new heights.

**GigaCloud Technology Inc. (GCT)**

Specializing in distribution services/wholesale distributors, GigaCloud Technology Inc. has seen its stock soar with a 1-year total return of 639%. The company’s business-to-business e-commerce solutions have gained traction, with expansions into new markets and consistent revenue growth driving its success.

**CleanSpark, Inc. (CLSK)**

Described as “America’s Bitcoin Miner,” CleanSpark has capitalized on the cryptocurrency boom with a 1-year total return of 596%. The company’s low-carbon mining centers and strategic positioning in the Bitcoin market have proven to be lucrative, with significant mining achievements contributing to its success.

**Aquestive Therapeutics, Inc. (AQST)**

Aquestive Therapeutics, operating in the health technology/pharmaceuticals sector, has delivered a remarkable 1-year total return of 492%. The company’s focus on developing orally administered alternatives to complex therapies, particularly its groundbreaking product Anaphylm, has garnered attention from investors and regulatory bodies alike.

**Selecting the Best Cheap Growth Stocks**

The selection of these growth stocks was based on their stock price appreciation over the past year. Companies trading under $50 per share and listed on the Nasdaq or NYSE were considered for inclusion. Growth stocks prioritize revenue growth over other metrics and reinvest capital back into the business to drive expansion. This focus on growth can lead to increased volatility compared to value stocks.

In conclusion, the allure of growth stocks in 2024 is undeniable, with companies like Root, Inc., EyePoint Pharmaceuticals, Inc., GigaCloud Technology Inc., CleanSpark, Inc., and Aquestive Therapeutics, Inc. showcasing the potential for substantial returns. As investors navigate the dynamic landscape of the stock market, understanding the nuances of growth stocks and their inherent risks is crucial for making informed investment decisions.

*Disclaimer: The comments, opinions, and analyses expressed in this article are for informational purposes only. The author does not own any of the mentioned stocks as of the date of writing.*

For more insights on growth stocks and market trends, visit [Investopedia](https://www.investopedia.com/cheap-growth-stocks-march-2024-8605511).

News Desk

- Advertisement -

Explore more

Jabil Stock Drops on Missed Sales and Guidance, Blames ‘Revenue Headwinds’...

The Challenges Faced by Jabil Inc. in Fiscal Year 2024 In recent news, Jabil Inc. (JBL) has experienced a significant setback in its second-quarter fiscal...

Ultimate Mediterranean Yacht Charter Experience | ORBITAL AFFAIRS

Picture yourself aboard a luxurious yacht, cruising through the breathtaking waters of the Mediterranean. With an endless stretch of glistening turquoise seas yoked by...
'Confirmed Release Date for 'Beyond Paradise' | ORBITAL AFFAIRS'

‘Confirmed Release Date for ‘Beyond Paradise’ | ORBITAL AFFAIRS’

Thankfully and unsurprisingly, Beyond Paradise will return for a second season. Beyond Paradise, a successful spin-off of Death in Paradise will transport viewers to...

Enphase Stock Slumps on Interest Rate Concerns and Insider Selling—Watch Levels...

Shares Lost 17% of Their Value Last Week
Robyn Bernard's Cause of Death Revealed! | ORBITAL AFFAIRS

Robyn Bernard’s Cause of Death Revealed! | ORBITAL AFFAIRS

Robyn Bernard’s cause of death has been a topic of speculation and concern, as fans and followers seek clarity surrounding the circumstances. The sudden...
Stock Movers: Adobe, Ulta Beauty, Jabil, and More

Stock Movers: Adobe, Ulta Beauty, Jabil, and More

The Stock Market Update: Adobe, Ulta Beauty, Jabil, and More Key Takeaways U.S. equities lost ground at midday Friday, March 15, 2024 as a...
Chris Cuomo's Literary Partner: The Write Side of Love | ORBITAL AFFAIRS

Chris Cuomo’s Literary Partner: The Write Side of Love | ORBITAL...

In the wake of Robyn Bernard’s untimely passing, the circumstances surrounding her cause of death have stirred intrigue and speculation. As fans and followers...
Unlocking Emma Stone's Ageless Beauty | ORBITAL AFFAIRS

Unlocking Emma Stone’s Ageless Beauty | ORBITAL AFFAIRS

Emma Stone, the acclaimed actress known for her versatility and charm, continues to captivate audiences worldwide. Born on November 6, 1988, in Scottsdale, Arizona,...